Nogo receptor knockdown and ciliary neurotrophic factor attenuate diabetic retinopathy in streptozotocin-induced diabetic rats

Introduction

Diabetes mellitus (DM) is the most common metabolic disease worldwide (1). DM may become the seventh leading cause of human death by the year 2030 (2). The complications of DM include microvascular (retinopathy, nephropathy and neuropathy) and macrovascular complications (cardiovascular disease) (3). Diabetic retinopathy (DR) is characterized by the increased vessel permeability and progressive vascular occlusion (4). DR is a main cause of visual impairment and blindness in adults (5). The pathogenesis of DR is multifactorial, such as hyperglycemia, advanced glycation end products, oxidative stress and inflammation (6,7).

Retinal ganglion cells (RGCs) are the final neurons in the retina that output vision signals to brain visual centers (8). The death of RGCs contributes to irreversible visual loss (9). Ciliary neurotrophic factor (CNTF) is a neurotrophic cytokine of the IL-6 family and can induce neuron differentiation in the central nervous system (10). Mathews et al have reported that CNTF administration promotes RGC survival and provides neuroprotection against ischaemic optic nerve injury in animal models (11). Aizu et al have found that topical instillation of CNTF via eye drops protects STZ-induced diabetic rats from retinal degeneration (12).

RhoA is a GTPase protein that regulates cytoskeleton reorganization in stress fiber formation (13). RhoA exerts its downstream effect via effector proteins, Rho-associated protein kinase 1 (Rock1) and Rock2 (14). Lu et al have demonstrated that RhoA/Rock1 signaling is involved in the protection of microvascular endothelial cell dysfunction induced by hyperglycemia in an in vitro model of DR (15). Nogo receptor (NgR) is a neural regeneration-associated membrane receptor for Nogo, oligodendrocyte-myelin glycoprotein and myelin-associated glycoprotein (16). Our previous study has demonstrated that NgR and Rock1 expression levels are elevated in the retina of diabetic rats. Downregulation of NgR inhibits retinal ganglion cell apoptosis and decreases Rock1 expression (17).

Our study focused on the effect of NgR inhibition and CNTF treatment on RGCs in DR in vivo. Furthermore, we evaluated the synergistic effect of combination therapy and the possible protective mechanisms. Our study provides a novel strategy for DR treatment.

Materials and methods

Animals and treatment

Male Sprague Dawley (SD) rats (weighting 200–250 g, purchased from Vital River, Beijing, China) were randomly assigned to 6 groups (n=24 per group): i) Control group, ii) STZ group, iii) STZ+control siRNA group, iv) STZ+NgR siRNA group, v) STZ+CNTF group and vi) STZ+NgR siRNA+CNTF group. The rats in the STZ group were treated intraperitoneally with a single injection of 65 mg/kg STZ (Solarbio, Beijing, China) dissolved in 0.01 M cold sodium citrate buffer and treated with saline. The control siRNA or NgR siRNA (5 µl and 3 µM) (GenePharma, Shanghai, China) were injected into the vitreous of diabetic rats in the STZ+control siRNA group or STZ+NgR siRNA group, respectively (This injection was repeated after 6 weeks). CNTF (1 µg) (Sino Biological, Beijing, China) were administrated into the vitreous of diabetic rats in the STZ+CNTF group once a week for 12 weeks. The rats in the STZ+NgR siRNA+CNTF group received NgR siRNA and CNTF after induction of diabetes. The rats in the control group received sodium citrate buffer and saline. Blood glucose level (mM) was detected 3 days post-STZ administration for diabetes induction confirmation (>16.7 mmol/l). All the rats were sacrificed after 12 weeks. The retinal tissues were excised and fixed in 4% paraformaldehyde for further analyses. The experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals and approved by Animal Care and Use Committee of Guangxi Medical University (Nanning, China).

H&E staining

The paraffin-embedded retinal tissues were sectioned into 5-µm slices. The sections were deparaffinized with xylene and graded ethanol (100, 95, 85 and 75% ethanol). The sections were stained with hematoxylin for 5 min and incubated with 1% hydrochloric acid alcohol for 3 sec, followed by staining with eosin for 3 min. Subsequently, the sections were dehydrated with graded ethanol (75, 85, 95, and 100% ethanol) and xylene. The sections were mounted with neutral gum and captured by OLYMPUS DP73 microscope (Olympus Corp., Tokyo, Japan).

TUNEL

The paraffin-embedded sections (5-µm thick) of retinal tissues were deparaffinized, treated with 0.1% Triton X-100 and blocked with 3% H2O2. After washing with PBS, the sections were incubated with the mixture of terminal deoxynucleotidyl transferase (TdT) and fluorescein-labeled dUTP and then treated with converter-POD according to the manufacturer's protocol (Roche, Basel, Switzerland). DAB was added and the sections were counterstained with hematoxylin. Finally, the sections were dehydrated and photographed under OLYMPUS DP73 microscope.

Western blotting

The retinal tissues were lysed on the ice, followed by protein extraction. The protein concentration was determined by BCA assay kit (Wanleibio, Shenyang, China). The proteins were subjected to SDS-PAGE (8–13%) and transferred to PVDF membranes. Then, membranes were blocked with non-fat milk dissolved in Tween-20/TBS buffer. Subsequently, the membranes were incubated with primary antibodies against NgR (1:10,000; ab184556; Abcam, Cambridge, UK), RhoA (1:200; sc-197; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), Rock1 (1:200; sc-374388; Santa Cruz Biotechnology, Inc.), Bcl-2 (1:400; BA0412; Boster, Wuhan, China), Bax (1:400; BA0315; Boster), Caspase-3 (1:1000; ab2302; Abcam), F-actin (1:500; ab205; Abcam), growth-associated protein-43 (GAP-43) (1:200; sc-33705; Santa Cruz Biotechnology, Inc.) at 4°C overnight and then with secondary antibody (1:5,000; horseradish peroxidase-labeled IgG; WLA023 and WLA024; Wanleibio) for 45 min at 37°C. The protein bands were visualized via ECL reagent and analyzed by Gel-Pro Analyzer (Media Cybernetics, Rockville, MD, USA).

Immunohistochemistry

Retinal tissue sections (5-µm thick) were deparaffinized with xylene and gradient ethanol (100, 95, 85 and 75% ethanol). After antigen retrieval, the sections were treated with H2O2 and blocked with goat serum. Then, sections were incubated with primary antibodies against F-actin (1:200; bs-1571R; Bioss, Beijing, China) and GAP-43 (1:200; D163002; Sangon Biotech, Shanghai, China) at 4°C overnight and biotin-labeled secondary antibody (1:200; A0277; Beyotime Institute of Biotechnology, Haimen, China) at 37°C for 30 min, followed by incubation with HRP-labeled avidin (A0303; Beyotime) at 37°C for 30 min. The sections were visualized with DAB, counterstained with hematoxylin and imaged under a microscope (Olympus Corp.).

Quantitative PCR (qPCR)

Total RNAs were extracted from the retinal tissues using RNApure Total RNA Extraction kit (BioTeke, Beijing, China) and reverse-transcribed to cDNAs using M-MLV Reverse Transcriptase (BioTeke). The volume of obtained cDNAs was 20 µl. qPCR analysis was carried out following the reaction conditions on Real-Time PCR system (BIONEER, Daejeon, Korea): 95°C for 10 min, followed by 40 cycles of 95°C for 10 sec, 60°C for 20 sec and 72°C for 30 sec. The primers used were as follows: NgR forward, 5′-GTCCCTTCCAGACCAATCAGC-3′ and reverse, 5′-GCCATTGCCTGGTGGAGTGT-3′; RhoA forward, 5′-TCGGAATGATGAGCACACAA-3′ and reverse, 5′-GCTTCACAAGATGAGGCAC-3′; Rock1 forward, 5′-GTGATGGCTATTATGGACG-3′ and reverse, 5′-AGGAAGGCACAAATGAGAT-3′; F-actin forward, 5′-GAAGAGAAAGCAGCAGTGTTA-3′ and reverse, 5′-GGAGCCAGAGGGTGGTTAT-3′; GAP-43 forward, 5′-AGGGAGATGGCTCTGCTAC-3′ and reverse, 5′-CACATCGGCTTGTTTAGGC-3′; GAPDH forward, 5′-CGGCAAGTTCAACGGCACAG-3′ and reverse, 5′-CGCCAGTAGACTCCACGACAT-3′. The primers were synthesized by Sangon Biotech. Gene expression was normalized to GAPDH and calculated using the 2−ΔΔCq formula.

Statistical analysis

Data are expressed as the mean ± SD and analyzed by Student's t-test for the comparison of every two groups. P<0.05 was considered to indicate a statistically significant difference.

Results

Effect of NgR siRNA and CNTF injection on the number of cells in GCL in diabetic rats

Histopathological examination showed that the cell numbers in GCL (Fig. 1) were decreased in diabetic rats compared with those in non-diabetic control rats. We found that NgR siRNA or CNTF injection alone increased the number of cells in GCL. Similarly, combination treatment further enhanced the ability of single treatment, although the difference was not statistically significant.

Figure 1. Effect of NgR siRNA and/or CNTF injection on the cell number in GCL in vivo. Diabetes was induced by STZ injection (65 mg/kg) in male SD rats. The diabetic rats were administrated with siRNA and/or CNTF. After animal experiments, the retina was excised from the sacrificed rats and subjected to H&E staining. Scale bars 50 µm. Number of cells in GCL was measured. **P<0.01 vs. STZ group. &&P<0.01 vs. STZ+control siRNA group.

Effect of NgR siRNA and CNTF injection on cell apoptosis in the retinal tissues of diabetic rats

Death of RGCs is one of the earliest events in DR occurrence and progression (18). Therefore, we evaluated cell apoptosis using TUNEL assay. As expected, diabetic rats presented higher apoptosis rate of the cells in the retina than control rats (Fig. 2A). However, NgR knockdown or CNTF incubation significantly protected RGCs against apoptosis in diabetic rats. Combined injection of NgR siRNA and CNTF decreased the apoptotic rate of RGCs in diabetic rats in comparison with the STZ+NgR siRNA group or STZ+CNTF group, however, no significant difference was observed between the single treatment group and the combination group. Next, we measured the levels of apoptosis-related proteins (Bax, Bcl-2 and Caspase-3) in the retinal tissues using western blotting. We demonstrated that Bax and Caspase-3 levels were significantly upregulated in the retinal tissues of diabetic rats compared with control rats, whereas anti-apoptotic protein Bcl-2 was downregulated (Fig. 2B). NgR siRNA alone and CNTF injection alone notably reversed diabetes-induced cell apoptosis by decreasing Bax and Caspase-3 levels and increasing Bcl-2 level. Compared with the STZ+NgR siRNA group or STZ+CNTF group, NgR siRNA injection combined with CNTF further enhanced the anti-apoptotic effect of NgR knockdown and CNTF.

Figure 2. Effect of NgR siRNA and/or CNTF injection on cell apoptosis in the retina in vivo. (A) Apoptosis was detected by TUNEL assay. Scale bars 50 µm. (B) Bcl-2, Bax and Caspase-3 protein levels were examined by western blotting. *P<0.05 and **P<0.01 vs. STZ group. &P<0.05 and &&P<0.01 vs. STZ+control siRNA group. $$P<0.01 vs. STZ+NgR siRNA group. ##P<0.01 vs. STZ+CNTF group.

Effect of NgR siRNA and CNTF injection on growth cone cytoskeleton and axonal regeneration

To evaluate the effect of NgR knockdown and CNTF treatment, either alone or in combination, on growth cone cytoskeleton and axonal regeneration, we measured the expression levels of F-actin and GAP-43 in the retinal tissues. We observed the downregulated expression of F-actin and GAP-43 at both protein (Fig. 3A) and mRNA levels (Fig. 3B) in the retinal tissues of diabetic rats. However, NgR siRNA or CNTF incubation significantly elevated the levels of these two proteins. Moreover, the combination of NgR siRNA and CNTF further increased F-actin and GAP-43 levels. We then performed IHC analysis (Fig. 3C) and verified the results obtained from western blotting and qPCR.

Figure 3. Effect of NgR siRNA and/or CNTF injection on F-actin and GAP-43 in vivo. (A) Western blot analysis of F-actin and GAP-43. (B) qPCR analysis of F-actin and GAP-43. (C) F-actin and GAP-43 were examined by IHC. Scale bars 50 µm. **P<0.01 vs. STZ group. &&P<0.01 vs. STZ+control siRNA group. $P<0.05 vs. STZ+NgR siRNA group. ##P<0.01 vs. STZ+CNTF group.

Effect of NgR siRNA and CNTF injection on NgR/RhoA/Rock1 signaling pathway

We then examined the effect of NgR knockdown and CNTF treatment, either alone or in combination, on the activation of NgR/RhoA/Rock1 signaling pathway in diabetic rats. The results showed that NgR, RhoA and Rock1 levels were elevated in diabetic rats in comparison with control rats, as demonstrated by western blotting (Fig. 4A) and qPCR (Fig. 4B). After injection with NgR siRNA or CNTF, the diabetic rats expressed lower levels of NgR, RhoA and Rock1 in the retinal tissues than the corresponding model rats. As expected, the expression of NgR, RhoA and Rock1 were significantly inhibited by the combined administration of NgR siRNA and CNTF compared with the single treatment group.

Figure 4. Effect of NgR siRNA and/or CNTF injection on NgR/RhoA/Rock1 signaling pathway in vivo. (A) NgR, RhoA and Rock1 levels were measured by western blotting. (B) NgR, RhoA and Rock1 levels were measured by qPCR. **P<0.01 vs. STZ group. &&P<0.01 vs. STZ+control siRNA group. $P<0.05 and $$P<0.01 vs. STZ+NgR siRNA group. ##P<0.01 vs. STZ+CNTF group.

Discussion

Understanding the pathological mechanisms of DR and targeting them are essential to DR prevention. In our study, we aimed to investigate the effect of NgR/RhoA/Rock1 signaling pathway inhibition and/or CNTF treatment on retinal ganglion cells in diabetic rats.

RGCs are the main part of nervous tissues in the retina and they relay visual signals to the brain (19). Apoptosis of RGCs plays an essential role in onset and progression of DR (20). Tong et al have demonstrated that NgR silencing inhibits C6 cell proliferation and promotes cell apoptosis (21). Wang et al have reported that CNTF protects neuroblastoma SH-SY5Y cells from cytotoxicity and apoptosis induced by amyloid beta peptide (Aβ1–42) (22). However, the effect of NgR knockdown or CNTF treatment and their synergistic effect on RGC-5 cells needed to be clarified. In our study, a rat model of DM was induced by a single injection of STZ (65 mg/kg). After administration of siRNAs or CNTF, the retinal tissues were excised and subjected to H&E staining to measure RGC count. The results showed that NgR siRNA or CNTF injection, as well as combined therapy, prevented diabetes-induced the loss of ganglion cells in GCL. B-cell-lymphoma 2 (Bcl-2) protein family members regulate cell apoptosis and this family consists of proapoptotic proteins (Bax and Bad) and antiapoptotic (Bcl-2 and Bcl-xL) (23). Bax is a soluble protein that usually exists in the cytosol. Bax translocates to mitochondrial membranes, enhances membrane permeabilization, results in cytochrome c release and thus induces apoptosis (24). However, Bcl-2 can inhibit the translocation of Bax in the cells undergo apoptosis (25). Apoptosis is the result of caspase cascades. Caspase-3 is the downstream executor of these cascades (26). The results showed that, consistent with previous study (27), diabetes induced RGC apoptosis in the retinal tissues, along with the increases of Bax and Caspase-3 and the decrease of Bcl-2. NgR siRNA or CNTF injection, as well as combined therapy, protected cells from diabetes-induced apoptosis by downregulating Bax and Caspase-3 and upregulating Bcl-2. Our results suggested that both single agent treatment and combination treatment alleviated diabetes-induced apoptosis by regulating the expression of apoptosis-related proteins in diabetic rats.

F-actin is a main element of cytoskeleton and functions in cell shape, motility and division (28). F-actin dynamics plays an important role in regulating axon extension (29). GAP-43, which belongs to the calmodulin-binding protein family, is a protein kinase C (PKC) substrate and is highly expressed in adult RGCs (30,31). Increased expression of GAP-43 correlates with cytoskeletal organization in nerve ending, neurite outgrowth and axon regeneration (32). Liu et al have found that CNTF attenuates gp120-induced inhibition of neurite outgrowth by elevating GAP-43 expression in dorsal root ganglion (DRG) explants (33). Our results showed that diabetes resulted in the loss of F-actin and GAP-43 in the retina. NgR siRNA, CNTF or combination injection prevented diabetes-induced loss of F-actin and GAP-43. Our results suggested that NgR siRNA, CNTF or combination injection may promote growth cone cytoskeleton and axonal regeneration by regulating F-actin and GAP-43.

RhoA, a small GTPase protein, is associated with the contractility of actin cytoskeleton (13). Moreover, RhoA has been demonstrated to be involved in cell proliferation, apoptosis and metastasis (34). Rock1 is a downstream target of RhoA (35). Peng et al have reported that RhoA/ROCK1 pathway is inhibited by simvastatin in the treatment of early-stage of diabetic nephropathy (DN) (36). Additionally, RhoA/ROCK1 pathway has been shown to be involved in the pathology of DR via triggering microvascular endothelial dysfunction (15). In our study, we demonstrated that NgR siRNA, CNTF or combination injection inhibited the activation of NgR/RhoA/Rock1 signaling pathway induced by diabetes.

In conclusion, the combination of NgR knockdown and CNTF treatment exhibits obvious advantages over either therapy alone. The combined therapy may be a potential therapeutic strategy for the treatment of DR.

Acknowledgements

This study was supported by a grant from the National Natural Science Foundation of China (grant no. 81571383).

References